Trial · NCT03904693
Results by group56
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 56
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Pulmonary Vascular Resistance (PVR) Expressed as the Ratio of Geometric Means of End of Double-blind Treatment (EDBT) to Baseline | DB: Treatment-naive And Prior ERA Strata: Macitentan Monotherapy 10 Milligrams (mg) | 0.77 | 95% Confidence Interval 0.69 to 0.87 | Ratio | |
| Change in Pulmonary Vascular Resistance (PVR) Expressed as the Ratio of Geometric Means of End of Double-blind Treatment (EDBT) to Baseline | DB: Treatment-naive And Prior ERA Strata: M/T FDC | 0.55 | 95% Confidence Interval 0.50 to 0.60 | Ratio | |
| Change in Pulmonary Vascular Resistance (PVR) Expressed as the Ratio of Geometric Means of End of Double-blind Treatment (EDBT) to Baseline | DB: Treatment-naive And Prior PDE-5i Strata: Tadalafil Monotherapy 20 mg (2 Tablets*20 mg) | 0.78 | 95% Confidence Interval 0.72 to 0.84 | Ratio | |
| Change in Pulmonary Vascular Resistance (PVR) Expressed as the Ratio of Geometric Means of End of Double-blind Treatment (EDBT) to Baseline | DB: Treatment-naive And Prior PDE-5i Strata: M/T FDC | 0.56 | 95% Confidence Interval 0.52 to 0.60 | Ratio | |
| Change From Baseline to EDBT in 6-minutes Walking Distance (6MWD) | DB: Treatment-naive And Prior ERA Strata: Macitentan 10 Milligrams (mg) | 38.5 | Standard Deviation 70.42 | Meters | |
| Change From Baseline to EDBT in 6-minutes Walking Distance (6MWD) | DB: Treatment-naive And Prior ERA Strata: M/T FDC | 52.9 | Standard Deviation 88.23 | Meters | |
| Change From Baseline to EDBT in 6-minutes Walking Distance (6MWD) | DB: Treatment-naive And Prior PDE-5i Strata: Tadalafil Monotherapy 20 mg (2 Tablets*20 mg) | 15.9 | Standard Deviation 45.04 | Meters | |
| Change From Baseline to EDBT in 6-minutes Walking Distance (6MWD) | DB: Treatment-naive And Prior PDE-5i Strata: M/T FDC | 43.4 | Standard Deviation 78.03 | Meters | |
| Change From Baseline in Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT) in Cardiopulmonary Symptom Domain Scores to EDBT | DB: Treatment-naive And Prior ERA Strata: Macitentan 10 Milligrams (mg) | -0.14 | Standard Deviation 0.478 | Score on a scale | |
| Change From Baseline in Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT) in Cardiopulmonary Symptom Domain Scores to EDBT | DB: Treatment-naive And Prior ERA Strata: M/T FDC | -0.20 | Standard Deviation 0.394 | Score on a scale | |
| Change From Baseline in Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT) in Cardiopulmonary Symptom Domain Scores to EDBT | DB: Treatment-naive And Prior PDE-5i Strata: Tadalafil Monotherapy 20 mg (2 Tablets*20 mg) | -0.13 | Standard Deviation 0.554 | Score on a scale | |
| Change From Baseline in Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT) in Cardiopulmonary Symptom Domain Scores to EDBT | DB: Treatment-naive And Prior PDE-5i Strata: M/T FDC | -0.15 | Standard Deviation 0.404 | Score on a scale | |
| Change From Baseline in Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT) in Cardiovascular Symptom Domain Scores to EDBT | DB: Treatment-naive And Prior ERA Strata: Macitentan 10 Milligrams (mg) | -0.14 | Standard Deviation 0.473 | Score on a scale | |
| Change From Baseline in Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT) in Cardiovascular Symptom Domain Scores to EDBT | DB: Treatment-naive And Prior ERA Strata: M/T FDC | -0.15 | Standard Deviation 0.349 | Score on a scale | |
| Change From Baseline in Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT) in Cardiovascular Symptom Domain Scores to EDBT | DB: Treatment-naive And Prior PDE-5i Strata: Tadalafil Monotherapy 20 mg (2 Tablets*20 mg) | -0.18 | Standard Deviation 0.612 | Score on a scale | |
| Change From Baseline in Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT) in Cardiovascular Symptom Domain Scores to EDBT | DB: Treatment-naive And Prior PDE-5i Strata: M/T FDC | -0.10 | Standard Deviation 0.318 | Score on a scale | |
| Percentage of Participants With Absence of Worsening in World Health Organization (WHO) Functional Class (FC) From Baseline at EDBT | DB: Treatment-naive And Prior ERA Strata: Macitentan 10 Milligrams (mg) | Stage: 1 : Class I | 5.6 | 0.590 to ? | Percentage of participants |
| Percentage of Participants With Absence of Worsening in World Health Organization (WHO) Functional Class (FC) From Baseline at EDBT | DB: Treatment-naive And Prior ERA Strata: M/T FDC | Stage: 1 : Class I | 5.3 | 0.561 to ? | Percentage of participants |
| Percentage of Participants With Absence of Worsening in World Health Organization (WHO) Functional Class (FC) From Baseline at EDBT | DB: Treatment-naive And Prior PDE-5i Strata: Tadalafil Monotherapy 20 mg (2 Tablets*20 mg) | Stage: 1 : Class I | 4.5 | 0.522 to ? | Percentage of participants |
| Percentage of Participants With Absence of Worsening in World Health Organization (WHO) Functional Class (FC) From Baseline at EDBT | DB: Treatment-naive And Prior PDE-5i Strata: M/T FDC | Stage: 1 : Class I | 12.8 | 0.546 to ? | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03904693/results